Lv1
100 积分 2025-05-28 加入
Mapping the disease interactome
3个月前
已关闭
The Evolving Applications of Bispecific Antibodies: Reaping the Harvest of Early Sowing and Planting New Seeds
3个月前
已完结
Trends and challenges in bispecific antibody production
3个月前
已完结
Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA‐Approved Bispecific Antibodies in Oncology
3个月前
已完结
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion
3个月前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
3个月前
已完结
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody
3个月前
已完结
CD38 x ICAM-1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma
3个月前
已完结
BCMAxCD3 Bispecific Yields Robust Responses in Myeloma
3个月前
已完结
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody
3个月前
已完结
皖公网安备34019202002308
